Accessibility Menu
 

Immunovia Ab (publ)

(OTC) IMMVF

Current Price$0.02
Market Cap$13.45M
Since IPO (2019)-100%
5 Year-100%
1 Year-60%
1 Month+0%

Immunovia Ab (publ) Financials at a Glance

Market Cap

$13.45M

Revenue (TTM)

$683.10K

Net Income (TTM)

$145.67M

EPS (TTM)

$-0.04

P/E Ratio

-0.50

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$0.02

Volume

600,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.15

IMMVF News

No articles available.

IMMVF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immunovia Ab (publ)

Industry

Healthcare Equipment and Supplies

Employees

13

CEO

Jeff Borcherding, MBA

Headquarters

Lund, 223 63, SE

IMMVF Financials

Key Financial Metrics (TTM)

Gross Margin

-23%

Operating Margin

-117%

Net Income Margin

-213%

Return on Equity

-362%

Return on Capital

-1%

Return on Assets

-2%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.45M

Shares Outstanding

672.67M

Volume

600.00K

Short Interest

0.00%

Avg. Volume

12.78K

Financials (TTM)

Gross Profit

$79.30M

Operating Income

$79.30M

EBITDA

$76.99M

Operating Cash Flow

$78.20M

Capital Expenditure

$0.00

Free Cash Flow

$78.20M

Cash & ST Invst.

$77.26M

Total Debt

$854.85K

Immunovia Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$353.10K

-22.4%

Gross Profit

$16.24M

-3669.7%

Gross Margin

-46.00%

N/A

Market Cap

$13.45M

N/A

Market Cap/Employee

$1.49M

N/A

Employees

9

N/A

Net Income

$17.28M

-663.0%

EBITDA

$15.57M

-456.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$76.41M

+210.1%

Accounts Receivable

$2.82M

-13.9%

Inventory

$118.69K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$854.85K

+25.7%

Return on Assets

-1.65%

N/A

Return on Invested Capital

-1.24%

N/A

Free Cash Flow

$19.73M

+30.2%

Operating Cash Flow

$19.73M

+30.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UEECUnited Health Products, Inc.
$0.06-1.72%
ASAPFAurora Spine Corporation
$0.20-0.20%
ZHCLFZenith Capital Corp.
$0.13+18.18%
ANPCYCelLBxHealth plc
$0.07+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$172.70-0.03%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About IMMVF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.